San Francisco – Aug. 19, 2021 – Real Chemistry’s IPM.ai, the leader in uncovering undiagnosed and misdiagnosed patients via machine learning, and Datavant, the leader in helping healthcare and...

Allison Rhee of MM&M reports on IPM.ai's answer to patient finding for rare and specialty diseases through advanced AI/ML. Read the full text below:

The rare disease patient journey can be arduous. Many patients experience multiple misdiagnoses or go undiagnosed before finally figuring out their true health issue and receiving treatment. For...

August 19, 2021

Real Chemistry's IPM.ai Expands Partnership with Datavant to Connect...

0

San Francisco – Aug. 19, 2021 – Real Chemistry’s IPM.ai, the leader in uncovering undiagnosed and misdiagnosed patients via machine learning, and Datavant, the leader in helping healthcare and...

August 9, 2021

IPM.ai's Clinical Trial Recruitment Solution Featured in MM&M

0

Allison Rhee of MM&M reports on IPM.ai's answer to patient finding for rare and specialty diseases through advanced AI/ML. Read the full text below:

August 6, 2021

Kyowa Kirin Uses AI/ML as a Solution for Uncovering Undiagnosed Tokenized...

0

The rare disease patient journey can be arduous. Many patients experience multiple misdiagnoses or go undiagnosed before finally figuring out their true health issue and receiving treatment. For...

July 29, 2021

Real Chemistry’s IPM.ai Accelerates the Clinical Investigation and...

0

Targeted Approach Optimizes Clinical Study Recruitment of Medically-Eligible Patients Affected by Rare Diseases

July 13, 2021

John Garcia of Alnylam Discusses Finding Patients With Rare Disease

0

Challenges are an inevitability when building a drug portfolio in the rare disease space, and patient finding is no doubt chief among them. Clinical trial recruitment is highly capital intensive,...

April 21, 2021

Using Non-Traditional Data to Unlock Disease Insights & Improve Outcomes

0

Though it’s not often discussed, often the most difficult aspect of bringing a drug to market is finding the right patient population. This is especially true with rare diseases, where patients...

January 19, 2021

IPM.ai and Momenta Featured at the 62nd Annual Meeting of the American Society...

0

Our own Julie Gubitosa and Graham Jones accompanied by Keith R. McCrae, MD of the Cleveland Clinic and Jennifer Beachell, Tricia Gooljarsingh PhD and Mary Lee Tjoa of Momenta Pharmaceutical,...

October 12, 2020

Using ML and AI to Infer HCP Specialties

0

Specialty Physician Identification: Your Best Targets Could Be Hiding In Plain Sight and You May Be Missing Them

October 11, 2020

Swoop Partners With IPM.ai for Pharmaceutical Ad Optimization

0

Real World Data and Social Determinants of Health can now be used for precision cross-channel pharmaceutical marketing campaigns